AMY MITCHELL: Open Payments
NPI 1043926736 · FREMONT, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$839 in 28 payments from 10 companies in 2025. Trend: 2023 $54 · 2024 $385 · 2025 $839
Food & beverage: $839
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 6 | $268 |
| Braeburn Inc. | 6 | $196 |
| Indivior Inc. | 4 | $111 |
| ABBVIE INC. | 4 | $93 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $65 |
| Alkermes, Inc. | 1 | $26 |
| Janssen Pharmaceuticals, Inc | 1 | $26 |
| Axsome Therapeutics, Inc. | 1 | $21 |
| Orexo US, Inc. | 1 | $18 |
| Supernus Pharmaceuticals, Inc. | 1 | $15 |
Products named: BRIXADI, AUSTEDO XR, UZEDY, SUBLOCADE, VRAYLAR, CAPLYTA, VIVITROL, SPRAVATO.
Industry payments across OH — which companies pay providers there.
